Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges.

Thomas DA.

Hematology Am Soc Hematol Educ Program. 2007:435-43. Review.

PMID:
18024662
2.

New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia.

Thomas DA, O'Brien S, Cortes J, Kantarjian H.

Curr Hematol Malig Rep. 2007 Jul;2(3):183-9. doi: 10.1007/s11899-007-0025-z. Review.

PMID:
20425368
4.
5.
6.

Philadelphia-positive acute lymphoblastic leukemia: current treatment options.

Liu-Dumlao T, Kantarjian H, Thomas DA, O'Brien S, Ravandi F.

Curr Oncol Rep. 2012 Oct;14(5):387-94. doi: 10.1007/s11912-012-0247-7. Review.

7.

Targeted chronic myeloid leukemia therapy: seeking a cure.

Fausel C.

J Manag Care Pharm. 2007 Oct;13(8 Suppl A):8-12. Review.

8.

Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Mathisen MS, O'Brien S, Thomas D, Cortes J, Kantarjian H, Ravandi F.

Curr Hematol Malig Rep. 2011 Sep;6(3):187-94. doi: 10.1007/s11899-011-0093-y. Review.

9.

Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.

Piccaluga PP, Paolini S, Martinelli G.

Cancer. 2007 Sep 15;110(6):1178-86. Review.

10.

Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Stock W.

Leuk Lymphoma. 2010 Feb;51(2):188-98. doi: 10.3109/10428190903452834. Review.

PMID:
20001232
12.

Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Hoelzer D, Gökbuget N, Ottmann OG.

Semin Hematol. 2002 Oct;39(4 Suppl 3):32-7. Review.

PMID:
12447850
13.

Imatinib for relapsed BCR/ABL positive leukemias.

Ottmann OG, Wassmann B, Hoelzer D.

Ann Hematol. 2002;81 Suppl 2:S36-7. Review. No abstract available.

PMID:
12611069
14.
15.
16.

Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Gruber F, Mustjoki S, Porkka K.

Br J Haematol. 2009 Jun;145(5):581-97. doi: 10.1111/j.1365-2141.2009.07666.x. Epub 2009 Apr 15. Review.

PMID:
19388927
17.

Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.

Thomas X, Dombret H.

Leuk Lymphoma. 2008 Jul;49(7):1246-54. doi: 10.1080/10428190801993504. Review.

PMID:
18452076
18.

Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving concepts.

Ottmann OG, Wassmann B.

Best Pract Res Clin Haematol. 2002 Dec;15(4):757-69. Review.

PMID:
12617875
19.

Managing Philadelphia chromosome-positive acute lymphoblastic leukemia: role of tyrosine kinase inhibitors.

Ravandi F.

Clin Lymphoma Myeloma Leuk. 2011 Apr;11(2):198-203. doi: 10.1016/j.clml.2011.03.002. Epub 2011 Apr 8. Review.

20.

Src kinase signaling in leukaemia.

Li S.

Int J Biochem Cell Biol. 2007;39(7-8):1483-8. Epub 2007 Feb 9. Review.

Supplemental Content

Support Center